ARF1 and neoplasm: Interestingly, a missense mutation of ARF1 (p.L148P), identified in a metastatic GIST tumor, was further verified in a relapsed GIST tumor of the test cohort, suggesting its potential role in GIST progression and therapeutic resistance.